John M. Burke, MD | Authors


Barriers to Access for COVID-19 Treatments Put Patients With Cancer at Risk

March 19, 2022

Amid the surge of the omicron variant, the FDA issued an emergency use authorization for the orally administered antiviral combination, which can reduce the rate hospitalization or death by 87% compared with no treatment.